Mesenchymal Stem Cells in Patients Diagnosed With COVID-19
Status:
Recruiting
Trial end date:
2020-12-30
Target enrollment:
Participant gender:
Summary
The propose of this study is implement adjuvant therapy with adipose tissue
derived-mesenchymal stem cells (MSCs) for critical COVID-19 patients admitted to the
intensive care unit of the Regional Hospital Lic. Adolfo López Mateos of the Institute for
Social Security and Services for State Workers to reduce cytokine storm and contribute to the
favorable resolution of respiratory insufficiency and multiple organic failure.